Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026)

Century Therapeutics' (IPSC) quarterly EPS (Basic) came in at -$0.47 in Q1 2026, down 152.8% year-on-year from $0.89 in Q1 2025, and down 326.02% on a QoQ basis from -$0.11 in Q4 2025.

Century Therapeutics (IPSC) EPS (Basic) (2020 - 2026) Analysis & Trends

Century Therapeutics (IPSC) has 7 years of EPS (Basic) data on file, last reported at -$0.47 in Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 152.8% year-over-year to -$0.47 in Q1 2026; TTM through Mar 2026 was -$0.87, a 245.48% decrease from a year earlier, with the FY2025 full-year figure at $0.02, up 101.49% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.47, down from -$0.11 in the prior quarter.
  • Over the last five years, EPS (Basic) for IPSC reached as high as $0.89 in Q1 2025 and fell as low as -$0.66 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$0.39 across 5 years, with a median of -$0.47 in 2026.
  • Across the five-year window, EPS (Basic) soared 297.58% in 2025 and plunged 152.8% in 2026, its largest moves.
  • Year by year, EPS (Basic) stood at -$0.55 in 2022, then declined by 21.09% to -$0.66 in 2023, then jumped by 31.71% to -$0.45 in 2024, then soared by 75.68% to -$0.11 in 2025, then slumped by 326.02% to -$0.47 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.47 in Q1 2026, -$0.11 in Q4 2025, and -$0.4 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Century Therapeutics 406.30 Mn 271.49 Mn - -0.47

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.47
Dec 31, 2025 -0.11
Sep 30, 2025 -0.40
Jun 30, 2025 -0.38
Mar 31, 2025 0.89
Dec 31, 2024 -0.45
Sep 30, 2024 -0.37
Jun 30, 2024 -0.38
Mar 31, 2024 -0.45
Dec 31, 2023 -0.66
Sep 30, 2023 -0.55
Jun 30, 2023 -0.56
Mar 31, 2023 -0.53
Dec 31, 2022 -0.55
Sep 30, 2022 -0.53
Jun 30, 2022 -0.54
Mar 31, 2022 -0.66
Dec 31, 2021 -0.87
Sep 30, 2021 -0.48
Jun 30, 2021 -1.93